Question 1

What are the potential benefits of using 18F-DCFPyL for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this imaging agent compare to other imaging methods I might have used?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any cost associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer clinical trial (NCT02151760). Contact the study team or your healthcare provider for specific answers.

What this study is about